Japanese researchers from RIKEN, Nippon Medical School, and Tohoku University developed a breakthrough AI method for cancer prognosis prediction. By incorporating medical knowledge through "intermediate reasoning scores," the system overcomes the dual challenges of institutional and specimen variations, achieving consistent predictions across different hospitals.

Japan leads smart contact lens development with groundbreaking innovations: holographic display technology from Tokyo University of Agriculture and Technology, SEED's open-source platform, and Waseda's electromagnetic shielding. Market projected to reach $10B by 2030. Discover how Japanese universities and companies are shaping the future of wearable tech.

SFTS, a tick-borne disease with 10-30% fatality rate. With treatment approved in 2024, early diagnosis is key. Japanese institutions including Osaka University are developing rapid diagnostic kits similar to flu tests. Record-high cases in 2025 with first Hokkaido infection raises nationwide concern.

Japanese researchers at Juntendo and Hiroshima Universities have discovered that soluble ST2 (sST2), naturally maintained at high levels in the body, suppresses food allergies by blocking IL-33 signaling. This groundbreaking finding identifies fibroblasts as the key sST2-producing cells and paves the way for new allergy prevention and treatment strategies.

Kyoto University researchers have identified the brain's "motivation brake" that prevents us from starting unpleasant tasks. The VS-VP neural pathway suppresses action initiation under stress. This breakthrough discovery opens new possibilities for treating depression and burnout syndrome.

Marking 20 years since Professor Shinya Yamanaka's groundbreaking iPS cell discovery, Japan advances toward world-first regulatory approval of regenerative medicine products in 2026. Explore the latest clinical trials for Parkinson's disease treatment and heart failure therapy, and discover how this Japanese innovation is revolutionizing global medicine.

Japanese startup Pormedtec targets 2027 for Japan's first pig-to-human organ transplant trials. With only 4% of 16,000 registered transplant candidates receiving organs annually, xenotransplantation offers hope. US trials show gene-edited pig kidneys functioning over 7 months in human patients. Will this breakthrough transform Japan's organ shortage crisis?